Ellen Bowden-Reid is a Research Associate with the Infection Analytics Program at the Kirby Institute. Through evidence-based research, she will utilise preclinical immunological evidence for vaccine development and approval.
In 2024, she completed a PhD in the area of early drug discovery, where her research focused on developing novel RNA-based therapies for HIV and SARS-CoV-2 using preclinical in vitro models of infection.